Serobeskyttelseshyppighederne for anti- HB’ erne (≥ 10 mlU/ ml), observeret ved 6, 10, 14 ugers programmet, var lavere som vist i tabellen herunder, men det er ke
The seroprotection rates for anti-HBs (≥ 10 mlU/ ml) observed with the 6, 10, 14 week schedule was lower as shown in the table below, but is unlikely to be clinically relevant due t uc